Intelligent Medicine Acqu...

NASDAQ: IQMDW · Real-Time Price · USD
0.00
-0.03 (-100.00%)
At close: Sep 17, 2024, 8:00 PM

Intelligent Medicine Acquisition Statistics

Share Statistics

Intelligent Medicine Acquisition has - shares outstanding. The number of shares has increased by null% in one year.

n/a
n/a
n/a
36.67%
n/a
n/a
n/a

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is 4.66 and the forward PE ratio is null. Intelligent Medicine Acquisition's PEG ratio is 0.

4.66
n/a
0
n/a
0.26
-61.37
0
Financial Ratio History

Enterprise Valuation

Intelligent Medicine Acquisition has an Enterprise Value (EV) of 53.15M.

0
-3.66
-61.31
-61.31

Financial Position

The company has a current ratio of 0.17, with a Debt / Equity ratio of 0.

0.17
0.17
0
n/a
n/a
0

Financial Efficiency

Return on Equity is 5.64% and Return on Invested Capital is -6.95%.

5.64%
5.33%
-6.95%
n/a
n/a
undefined
0
n/a

Taxes

562.57K
4.7%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so Intelligent Medicine Acquisition's price volatility has been lower than the market average.

0
n/a
0.03
0.06
43.7
n/a

Income Statement

n/a
n/a
-14.77M
11.41M
-14.54M
-14.54M
2.2
Full Income Statement

Balance Sheet

The company has 50.15K in cash and 0 in debt, giving a net cash position of 50.15K.

50.15K
n/a
n/a
-10.86M
214.03M
-891.12K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -866.9K and capital expenditures 0, giving a free cash flow of -866.9K.

-866.9K
n/a
-866.9K
-0.17
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

IQMDW does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
21.45%
-1.63%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for IQMDW.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

67320.23
2